IH may induce metabolic disorders by impairing pancreatic β-cell function, causing inflammatory responses in adipose tissue, and increasing glucose production in the liver, which interferes with insulin signaling pathways and disrupts glucose metabolism (19, 20). This evidence concerns the gene INS and metabolic disease.